GALVANI Trademark

Trademark Overview

On Wednesday, February 3, 2016, a trademark application was filed for GALVANI with the United States Patent and Trademark Office. The USPTO has given the GALVANI trademark a serial number of 86896322. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 5, 2024. This trademark is owned by Glaxo Group Limited. The GALVANI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
galvani

General Information

Serial Number86896322
Word MarkGALVANI
Filing DateWednesday, February 3, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 5, 2024
Registration Number5293823
Registration DateTuesday, September 26, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 5, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGALVANI BIOELECTRONICS LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type05 - Joint Venture
AddressBRENTFORD, MIDDLESEX TW89GS
GB
Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Monday, May 23, 2016NON-FINAL ACTION WRITTEN
Saturday, February 6, 2016NEW APPLICATION ENTERED
Monday, February 8, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 17, 2016ASSIGNED TO EXAMINER
Monday, May 23, 2016NON-FINAL ACTION WRITTEN
Monday, May 23, 2016NON-FINAL ACTION E-MAILED
Monday, May 23, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 23, 2016NON-FINAL ACTION E-MAILED
Monday, May 23, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 6, 2016EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, July 1, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 8, 2016ASSIGNED TO LIE
Monday, July 18, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 18, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 8, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 9, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 24, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 13, 2016PUBLISHED FOR OPPOSITION
Tuesday, September 13, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 16, 2017NOTICE OF ALLOWANCE CANCELLED
Friday, June 30, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 21, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, September 26, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, April 18, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, January 27, 2017EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 14, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 16, 2017TEAS DELETE 1(B) BASIS RECEIVED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 23, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 23, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 23, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 23, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, September 23, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 23, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, September 26, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 5, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

galvani pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological